Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

HOPA 2018

21–24 March 2018 | Denver, CO

The 2018 Hematology/Oncology Pharmacy Association (HOPA) Annual Conference, held in Denver, CO, took place on the 21–24 March. HOPA 2018 showcased the latest developments in hematology and oncology pharmacy practice.

Highlights from this year’s conference include the important roles of the pharmacist’s in hemato-oncology, the benefits of performing outpatient transplant and treating GvHD.

Personalized therapy in leukemia: a case study

Personalized therapy in leukemia: a case study

Patrick Kiel • 29 Aug 2018

Benefits of performing outpatient transplant

Benefits of performing outpatient transplant

Jeanne McCarthy-Kaiser • 21 Mar 2018

Patient education is important for drug tolerance and adherence

Patient education is important for drug tolerance and adherence

Jeanne McCarthy-Kaiser • 21 Mar 2018

The role of the pharmacist in transplant

The role of the pharmacist in transplant

Jeanne McCarthy-Kaiser • 21 Mar 2018

Treating GvHD: current challenges and newly approved drugs

Treating GvHD: current challenges and newly approved drugs

Katie Gatwood • 21 Mar 2018

The importance of pharmacist intervention in the treatment of GvHD with ruxolitinib and ibrutinib

The importance of pharmacist intervention in the treatment of GvHD with ruxolitinib and ibrutinib

Katie Gatwood • 21 Mar 2018

Ruxolitinib and ibrutinib: the future for GvHD treatment?

Ruxolitinib and ibrutinib: the future for GvHD treatment?

Katie Gatwood • 21 Mar 2018